| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cormedix Inc. (CRMD) has 10 insiders with recent SEC Form 4 filings, including 2 buys and 21 sells. CRMD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 774.7K | $6.83M | - | |
| COO | 278.5K | $2.46M | - | |
| Other | 269.1K | $2.37M | - | |
| Dir | 201.0K | $1.77M | - | |
| Other | 133.2K | $1.17M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2016 | Pfaffle Antony | Interim Chief Medical Officer | Sale+OE | 10,000 | $2.38 | $23,789.00 | -100% | |
| Jun 8, 2016 | Dillione Janet63 | Director | Buy | 3,738 | $2.67 | $9,980.46 | +24.9% | |
| Jun 3, 2016 | Duffy Matthew | Director | Sell | 46,106 | $2.73 | $126,007.70 | -61.7% | |
| May 31, 2016 | Lefkowitz Steven W | Director | Sell | 50,000 | $2.88 | $144,178.28 | -15.3% | |
| May 25, 2016 | Tellez Cora M | Director | Buy | 8,600 | $2.90 | $24,940.00 | +9.7% | |
| May 24, 2016 | Pfaffle Antony | Interim Chief Medical Officer | Sale+OE | 12,700 | $2.73 | $34,655.55 | -55.0% | |
| May 23, 2016 | Pfaffle Antony | Interim Chief Medical Officer | Sale+OE | 15,000 | $2.89 | $43,308.24 | -53.2% | |
| May 23, 2016 | Lefkowitz Steven W | Director | Sale+OE | 30,000 | $2.93 | $87,957.80 | -9.1% | |
| May 19, 2016 | Pfaffle Antony | Interim Chief Medical Officer | Sale+OE | 12,300 | $2.82 | $34,682.58 | -51.0% | |
| May 16, 2016 | Pfaffle Antony | Interim Chief Medical Officer | Sale+OE | 60,000 | $2.68 | $160,966.00 | -40.0% |